A brand new trial has been introduced that can take a look at whether or not a booster vaccine will defend in opposition to new variants.
All seven vaccines the UK has ordered will likely be examined on working-age folks and over-75s as a part of a randomised trial.
The findings will assist vaccine advisers resolve if re-vaccinating some folks within the autumn is important.
The examine, which prices £19.3 million, is being funded by the federal government and led by the College Hospital Southampton NHS Basis Belief.
Talking at Downing Road, the Well being Secretary, Matt Hancock, stated the trial would assist to make sure “vaccines keep forward of the virus.”